Related Experiment Video
Updated: Jun 4, 2026
09:11
Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release
Published on: February 13, 2016
Magnetically triggered nanocomposite membranes: a versatile platform for triggered drug release
Todd Hoare1, Brian P Timko, Jesus Santamaria
1Department of Chemical Engineering, McMaster University, 1280 Main Street West, Hamilton, Ontario L8S 4L7, Canada.
Nano Letters
|February 25, 2011
Summary
This study introduces novel nanocomposite membranes for controlled drug delivery. These membranes utilize magnetic fields to reversibly control drug release, offering tunable and reproducible dosing for various drug types.
Area of Science:
- Materials Science
- Biomedical Engineering
- Nanotechnology
Background:
- Conventional drug delivery systems often lack precise control over release kinetics.
- The development of smart materials for on-demand drug release remains a significant challenge in pharmaceutical science.
Purpose of the Study:
- To develop and characterize nanocomposite membranes for magnetically controlled, on-off drug delivery.
- To demonstrate the tunability and reproducibility of drug release using these novel membrane devices.
Main Methods:
- Fabrication of nanocomposite membranes incorporating thermoresponsive nanogels and superparamagnetic nanoparticles.
- Application of oscillating magnetic fields to induce reversible drug release.
- Modulation of drug delivery dose by adjusting nanogel phase transition temperature, nanogel loading density, and membrane thickness.
Main Results:
- Achieved on-state drug delivery over two orders of magnitude (0.1-10 microg/h) with tunable zero-order kinetics.
- Demonstrated successful delivery of drugs across a broad molecular weight range (500-40000 Da).
- Confirmed membrane-to-membrane and cycle-to-cycle reproducibility of drug release.
Conclusions:
- Nanocomposite membranes offer a versatile platform for magnetically controlled drug delivery.
- The system allows for precise tuning of drug dosage and release profiles.
- These findings suggest broad utility for these membranes in advanced therapeutic applications.
Related Concept Videos
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:23Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:22Modified-Release Drug Delivery Systems: Drug Release Characteristics
Drug release from modified-release dosage forms is designed to achieve specific therapeutic effects by controlling the rate and extent of drug release. The classification of these drug release systems is based on key pharmacokinetic assumptions: drug disposition follows first-order kinetics, drug release is the rate-limiting step in absorption, and the released drug is rapidly and completely absorbed.There are four major models of drug release patterns. The first model is the slow zero-order...